文献速递临床免疫临床生化

探针提取结合液相色谱-高分辨质谱直接检测未修饰单克隆血清游离轻链的克隆性

Clonality Determination by Detecting Unmodified Monoclonal Serum Free Light Chains Using On-Probe Extraction Coupled with Liquid Chromatography-High-Resolution Mass Spectrometry.
PubMed 文献 · Clin Chem · 2024-01-01

本研究开发了将探针提取(OPEX)与液相色谱-高分辨质谱(LC-HR-MS)联用的OPEX-MS方法,用于直接测定血清游离轻链(FLC)的克隆性。在免疫测定FLC升高的四组患者样本中,OPEX-MS通过保留时间和去卷积质量区分单克隆FLC。结果显示,49例κ型FLC升高样本中16例(33%)及100例κ和λ双型FLC升高样本中83例(83%)未检出单克隆FLC,提示OPEX-MS可作为免疫测定结果难以解释时的补充方法。

要点

  • OPEX-MS可直接检测未修饰单克隆血清游离轻链的克隆性。
  • 免疫测定FLC轻度升高的样本中常无单克隆FLC。
  • OPEX-MS可作为免疫测定结果难以解释时的补充方法。

核心结论

  • OPEX-MS方法能够直接测定血清游离轻链的克隆性,可作为免疫测定结果难以解释患者的补充手段。

研究设计与样本

  • 研究开发了将探针提取(OPEX)与液相色谱-高分辨质谱(LC-HR-MS)联用的OPEX-MS方法。
  • 使用载有抗κ或抗λ轻链抗体的微探针进行OPEX免疫捕获,捕获蛋白经反相液相色谱分离后行高分辨质谱分析。
  • 基于免疫测定FLC结果,检测了来自不同患者的四组样本。

主要发现

  • OPEX-MS的LC-HR-MS分析可提供每个克隆的独特保留时间以及FLC单体和二聚体的去卷积质量。
  • 49例κ型FLC升高样本中16例(33%)未检出单克隆FLC。
  • 100例κ和λ双型FLC升高样本中83例(83%)未检出单克隆FLC。

临床怎么用

  • 对于免疫测定FLC结果难以解释的患者,可考虑采用OPEX-MS直接检测单克隆FLC以辅助判断克隆性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serum free light chains (FLCs) are an essential clinical biomarker for the diagnosis and monitoring of patients with plasma cell neoplasms. The current widely used immunoassay methods quantify total serum FLCs, which include monoclonal FLCs as well as FLCs in the polyclonal background. Patients with chronic diseases, inflammatory disorders, or renal dysfunction can have elevated total FLCs that lead to ambiguous results. These patients may benefit from a direct measurement of monoclonal FLCs. The purpose of this study was to develop a method that couples on-probe extraction (OPEX) with liquid chromatography-high-resolution mass spectrometry (LC-HR-MS), abbreviated to OPEX-MS, to directly determine the clonality of FLCs. METHODS: OPEX immunocapture was performed using microprobes loaded with anti-kappa or anti-lambda light chain antibodies. Captured proteins were separated by reversed-phase LC and analyzed by HR-MS. RESULTS: Four cohorts of samples from unique patients were tested based on immunoassay FLC results. The LC-HR-MS analysis in the OPEX-MS method provides both a unique retention time along with deconvoluted masses of FLC monomers and dimers for each clone. The study found that 16 out of 49 (33%) kappa FLC elevated samples as well as 83 out of 100 (83%) dual kappa and lambda FLC elevated samples did not have monoclonal FLCs, which is consistent with the knowledge that there is often no clonal population in samples with mildly elevated FLC immunoassay results. CONCLUSIONS: The OPEX-MS method can serve as a complementary approach to directly determine clonality in patients with difficult-to-interpret FLC immunoassay results.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Yeung PSW, Liu Y, Yang S, et al. Clonality Determination by Detecting Unmodified Monoclonal Serum Free Light Chains Using On-Probe Extraction Coupled with Liquid Chromatography-High-Resolution Mass Spectrometry. Clin Chem. 2024. PMID: 39378225. doi:10.1093/clinchem/hvae130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。